Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$143K Hold
20,111
0.01% 353
2024
Q4
$184K Sell
20,111
-500
-2% -$4.68K 0.01% 325
2024
Q3
$200K Sell
20,611
-17,583
-46% -$185K 0.01% 337
2024
Q2
$311K Hold
38,194
0.03% 230
2024
Q1
$308K Buy
38,194
+17,583
+85% +$124K 0.03% 202
2023
Q4
$113K Hold
20,611
0.01% 223
2023
Q3
$108K Hold
20,611
0.01% 195
2023
Q2
$238K Hold
20,611
0.03% 164
2023
Q1
$257K Buy
+20,611
New +$395K 0.03% 154

Other funds holding INGN

Callan Capital's INGN Position: Q1 2025 in Review

Callan Capital held its Inogen (INGN) position steady in Q1 2025 at 20,111 shares worth $143K. The position accounts for 0.01% of the portfolio, ranked #353.

Callan Capital first reported a position in INGN in Q1 2023 and has held it in 9 quarters since. The position peaked at $311K in Q2 2024. 128 funds tracked by Wall St. Rank hold INGN as of Q1 2025.

  • Callan Capital held 20,111 shares of Inogen worth $143K as of Q1 2025.
  • Callan Capital left its Inogen share count unchanged in Q1 2025.
  • Inogen made up 0.01% of Callan Capital's portfolio in Q1 2025, its #353 holding.
  • Callan Capital first reported a position in Inogen in Q1 2023 and has held it in 9 quarters since.
  • Callan Capital's Inogen position peaked at $311K in Q2 2024.
  • 128 funds tracked by Wall St. Rank held Inogen as of Q1 2025.

Based on Callan Capital's 13F filing for Q1 2025, filed 29 Apr 2025.